VENTO, Sandro
 Distribuzione geografica
Continente #
NA - Nord America 3.818
EU - Europa 3.411
AS - Asia 2.442
SA - Sud America 537
AF - Africa 67
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.287
Nazione #
US - Stati Uniti d'America 3.753
RU - Federazione Russa 1.221
SG - Singapore 1.111
GB - Regno Unito 839
CN - Cina 626
BR - Brasile 451
VN - Vietnam 254
DE - Germania 211
SE - Svezia 203
FR - Francia 196
IE - Irlanda 192
FI - Finlandia 187
IT - Italia 186
HK - Hong Kong 184
KR - Corea 82
UA - Ucraina 66
AR - Argentina 35
CA - Canada 32
IN - India 31
ZA - Sudafrica 23
NL - Olanda 22
TR - Turchia 22
BD - Bangladesh 20
MX - Messico 19
ID - Indonesia 18
JP - Giappone 18
ES - Italia 17
BE - Belgio 16
NG - Nigeria 16
EC - Ecuador 14
CZ - Repubblica Ceca 12
PL - Polonia 12
CO - Colombia 11
IL - Israele 11
IQ - Iraq 9
SA - Arabia Saudita 9
AU - Australia 8
PK - Pakistan 8
CL - Cile 7
MA - Marocco 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
PY - Paraguay 6
AT - Austria 5
ET - Etiopia 5
LT - Lituania 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
NP - Nepal 4
AM - Armenia 3
DZ - Algeria 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PH - Filippine 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TW - Taiwan 1
Totale 10.287
Città #
Southend 726
Singapore 621
Jacksonville 602
Woodbridge 459
Chandler 380
Moscow 363
San Jose 324
Ashburn 259
Ann Arbor 198
Dublin 192
Dallas 187
Hong Kong 181
The Dalles 108
Houston 104
Verona 93
Beijing 87
Lawrence 77
Princeton 77
Ho Chi Minh City 74
Wilmington 72
Hanoi 64
Nanjing 63
Los Angeles 57
New York 54
Jinan 46
Shenyang 45
São Paulo 38
Buffalo 31
Santa Clara 30
Helsinki 29
Hebei 28
Munich 25
Nanchang 24
Changsha 23
Frankfurt am Main 23
Milan 23
Sindelfingen 23
Tianjin 23
Turku 22
Redondo Beach 21
Jiaxing 19
Denver 17
Ningbo 17
Seattle 17
San Francisco 16
Brussels 15
Haikou 15
Haiphong 15
London 15
Orem 15
Tokyo 15
Toronto 15
Abuja 14
Zhengzhou 14
Atlanta 13
Norwalk 13
Rio de Janeiro 13
Amsterdam 12
Bologna 12
Hangzhou 12
Taizhou 12
Warsaw 12
Belo Horizonte 11
Boardman 11
Guangzhou 11
Lanzhou 11
Brno 10
Brooklyn 10
Johannesburg 10
Montreal 10
Taiyuan 10
Chennai 9
Curitiba 9
Fairfield 9
Porto Alegre 9
Biên Hòa 8
Chicago 8
Da Nang 8
Phoenix 8
Poplar 8
Stockholm 8
Boston 7
Council Bluffs 7
Redmond 7
Tashkent 7
Thái Nguyên 7
Fuzhou 6
Limeira 6
Madrid 6
Mumbai 6
Quito 6
Redwood City 6
Salvador 6
Santo André 6
Seoul 6
Addis Ababa 5
Baghdad 5
Can Tho 5
City of London 5
Clearwater 5
Totale 6.486
Nome #
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 201
Aetiology of pneumonia following isolated closed head injury 199
Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS 191
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 185
A case of visceral leishmaniasis with protracted incubation in a nonendemic area. 184
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 177
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 172
Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance 171
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 171
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 170
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 168
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 168
Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis. 165
Can we really identify HIV-1 long-term nonprogressors? 163
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 163
Clinical picture: Ring calcification in the chest X-ray of a 17-year-old girl: coronary aneurism following Kawasaki disease 162
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 161
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 161
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 158
Does tenofovir increase efavirenz hepatotoxicity? 158
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 154
Adherence to HAART in HIV. 151
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy. 150
Autoimmune hepatitis type 1 after measles 148
Mortality due to hepatitis C virus-related cirrhosis in patients infected with HIV type 1: a role for alcohol 146
Early detection of lung cancer in high-risk patients with HIV-1 infection. 145
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 145
Diagnosis, management and outcome of clinically-suspected spinal infection 144
Hepatitis A virus infection and atherosclerosis 139
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 138
Hyperacute unilateral gonococcal endophthalmitis in an HIV-infected man without genital infection 138
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
[CD4+ guided interruption HAART in HIV patients] 134
Failure of prophylaxis against PCP in patients with HIV infection 131
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equi 131
Tuberculosis among refugees and displaced people at the Burundi-Rwanda border 130
Early detection of lung cancer in high-risk patients with HIV-1 infection. 129
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes. 127
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C 126
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 126
Effect of pregnancy on chronic hepatitis C 126
Nosocomial Candidemia in non-neutropenic patients at an Italian tertiary care hospital 124
Inflammatory pseudotumor of lymph nodes. 124
The PraSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria 123
Initial hospitalization and adherence to highly active antiretroviral therapy. 123
Syphilis in prostitutes from Eastern Europe. 123
Multdrug-resistant tuberculosis 121
Successful treatment of Castleman’s disease with HAART in two HIV-infected patients 121
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 120
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman. 119
M. tuberculosis drug resistance in AIDS 119
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 119
Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. 118
Highly active antiretroviral therapy. 117
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B. 114
Infection with hepatitis G virus in immunoglobulin recipients 113
MHC class I molecules and progression to AIDS 110
Human immunodeficiency virus-associated peripheral neuropathies 110
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus 109
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands 109
Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. 108
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. 108
HIV-1 progression in hepatitis-C- infected drug users 106
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals 106
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis. 105
Selective drug taking during combination antiretroviral therapy. 104
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 104
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 101
Highly active antiretroviral therapy. 100
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. 100
Resolution of autoimmune hepatitis after bone-marrow transplantation 98
Esophageal cryptococcosis in a patient with AIDS. 98
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis. 98
No increase in liver decompensation risk with atypical hepatitis C virus antibody pattern. 95
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. 93
Isolated Presence of Antibody to Hepatitis B core antigen in injection drug users: do they need to be vaccinated? 90
Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection. 86
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 81
Totale 10.358
Categoria #
all - tutte 34.223
article - articoli 34.223
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 14 79 11
2021/2022640 47 200 7 27 13 20 12 37 29 29 53 166
2022/20231.179 84 113 121 169 139 275 5 76 150 7 25 15
2023/2024406 27 36 44 44 69 51 5 9 2 9 52 58
2024/20251.385 106 83 26 222 60 24 69 37 254 92 93 319
2025/20263.864 293 264 264 760 1.023 252 321 201 349 137 0 0
Totale 10.358